A strategy for preventing sexually transmitted infections (STIs) appears to be rapidly losing effectiveness against gonorrhea ...
WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced that positive results from the Phase 3 oral zoliflodacin trial ...
Add Yahoo as a preferred source to see more of our stories on Google. The _Neisseria gonorrhoeae_ bacterium causes gonorrhea by infecting mucous membranes. Design Cells/iStock Getty Images Plus via ...
Add Yahoo as a preferred source to see more of our stories on Google. Neisseria gonorrhoeae is the type of bacteria that causes gonorrhea, a sexually transmitted infection. - Center for Disease ...
The Massachusetts Department of Public Health announced on Thursday two cases of a novel strain of gonorrhea—one which is resistant to five classes of antibiotic treatment, and which health officials ...
For the first time in decades, the U.S. Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection ...
A phase 2 clinical trial led by Stephanie N. Taylor, MD, Professor of Medicine and Microbiology in the Section of Infectious Diseases at LSU Health New Orleans School of Medicine, has found that a new ...
Neisseria gonorrhoeae bacteria, as seen in this illustration, consist of a pair of cells, called diplococci, and have hair-like pili on their surfaces. They can cause the sexually transmitted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results